CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- 4 Open-market sale Chief Medical Officer sold 165,000 shares at an average $7.68 ($1,267,750)
- 4 Exercise or conversion Director acquired 4,296 shares (option exercise)
- 4 Grant or award Director acquired 24,784 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President and CEO acquired 100,000 shares (option exercise)
- 4 Open-market sale Director sold 12,877 shares at $6.25 ($80,481)
- 4 Grant or award Director acquired 17,525 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Grant or award Director acquired 14,888 shares (grant or award)
- 4 Exercise or conversion Director acquired 13,228 shares (option exercise)
- 4 Open-market sale Director sold 5,000 shares at $5.75 ($28,735)
- 4 Exercise or conversion Chief Scientific Officer acquired 25,200 shares (option exercise)
- 4 Shares withheld for taxes President and CEO gave up 233,859 shares (to pay taxes)
- 4 Open-market sale Chief Operating Officer sold 37,149 shares at $6.38 ($236,925)
- 4 Open-market sale Chief Financial Officer sold 29,331 shares at $6.38 ($187,064)
- 4 Open-market sale President and CEO sold 156,407 shares at $6.38 ($997,517)
- 4 Open-market sale Chief Scientific Officer sold 23,775 shares at $6.38 ($151,630)
Page 9 of 36 · 701 filings